Avera Pharmaceuticals Inc.

 
• By Marc Wortman

Avera Pharmaceuticals Inc. is betting that there are enough promising neurological and psychiatric drugs gathering dust on the shelves of Big Pharma to support a substantial specialty business. It is starting out with a portfolio of neuromuscular blocker compounds acquired from GlaxoSmithKline PLC.

More from Archive

More from Scrip